Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Inmune Bio ( (INMB) ) has provided an announcement.
INmune Bio Inc. authorized stock options for its non-employee directors and key executives, allowing them to purchase shares at $5.05 under the 2021 Stock Incentive Plan. These options, granted on December 4, 2024, will be fully vested by December 5, 2026, and expire in 2034, providing an opportunity for potential long-term gains as part of their compensation strategy.
For a thorough assessment of INMB stock, go to TipRanks’ Stock Analysis page.
